OHB’s Record Backlog and Political Tailwinds Collide With a Post-Capital-Raise Hangover
Published on 07/30/2026 at 03:51 | Redaktion boerse-global.de
The arithmetic of OHB’s recent capital increase is proving unforgiving for shareholders. Shares in the Bremen-based space and defence group closed Wednesday at €230.50, roughly 20.7% below their level 30 days ago and well adrift of the €300 per share price at which the company placed new stock with institutional investors. The relative strength index has sunk to 31.4, deep in oversold territory, confirming that the selling pressure from the €484 million capital injection has yet to fully clear.
OHB completed the two-tranche transaction on 9 July, with a private placement raising €481.6 million and a subscription offer to existing shareholders contributing a further €2.3 million. Trading in the new shares from the second tranche began on 14 July on the Frankfurt Stock Exchange’s Prime Standard. Because the current market price sits so far below the issue price, the freshly minted stock continues to weigh on the quotation. The company’s total voting rights now stand at 19,208,280, formally closing the book on a capital measure that has left the stock trading below its 200-day moving average of €242.76 — a gap of more than 4.6%.
The dilution has been compounded by a separate transaction in late June, when the financial investor KKR, through its vehicle Orchid Lux HoldCo, placed 1,394,612 existing OHB shares with institutional investors while the company simultaneously placed 1,605,388 new shares. The free float is expected to rise to just over 20% as a result, while the founding Fuchs family retains a controlling stake of more than 60%.
A Business Story That Contradicts the Chart
The technical damage stands in stark contrast to the operational momentum. OHB reported a record order backlog of €3.35 billion as of 31 March 2026, a 45% increase year-on-year. That figure will take centre stage when the company publishes its half-year report on 6 August, accompanied by an investor presentation. The question hanging over the stock is whether that backlog is translating into revenue and earnings growth, or whether margin pressure is eating into the headline numbers.
Should investors sell immediately? Or is it worth buying OHB SE?
Shareholders approved a dividend of €0.60 per share for the 2025 financial year at the annual general meeting on 8 June, and elected Theodor Weimer, the former CEO of Deutsche Börse AG, to the supervisory board. In a separate strategic move, OHB struck a partnership with Schwarz Digits, the IT arm of the Schwarz Group, to deploy artificial intelligence in industrialised satellite manufacturing.
Political and Programme Milestones
Defence Minister Boris Pistorius visited OHB’s Bremen headquarters on 14 July, where he reaffirmed plans to expand Germany’s domestic launch capabilities for carrier rockets — a signal that underscores the company’s strategic importance to national security policy. On 24 July, OHB and the European Spaceport Company publicly welcomed the minister’s push for sovereign launch infrastructure.
On the programme side, the OHB System AG subsidiary granted MDA Space UK an advance project authorisation on 21 July to begin developing landing sensors for the European Space Agency’s Argonaut lunar mission. The early go-ahead allows MDA to start work before the formal prime contract is signed, a common practice in space programmes designed to keep schedules on track. For OHB, the milestone confirms that Europe’s moon exploration effort is proceeding as planned.
OHB SE at a turning point? This analysis reveals what investors need to know now.
The Earnings Test
The half-year numbers due on 6 August will serve as the stock’s next major catalyst. Investors will be looking for evidence that the record order book is feeding through to the profit-and-loss statement, and for any colour on margins following the capital increase. Management will have another opportunity to make its case to institutional investors on 21 September, when OHB is scheduled to appear at the Berenberg & Goldman Sachs German Corporate Conference.
For now, the picture remains split: a company with tangible programme progress, political backing and a bulging order pipeline, versus a stock that is technically bruised and still digesting the largest capital injection in its history. The next set of quarterly numbers will determine which side of that equation wins out.
Ad
OHB SE Stock: New Analysis - 30 July
Fresh OHB SE information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
